Vitrolife AB (VITR.ST) stock: key figures, P/E, revenue and dividend
Health Care · Sweden · ISIN SE0011205202
Vitrolife AB financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 3.61 bn SEK | 3.44 bn SEK |
| Gross profit | 2.13 bn SEK | 1.75 bn SEK |
| Operating income | 792.00 m SEK | 574.00 m SEK |
| EBIT | 783.00 m SEK | 616.00 m SEK |
| Net income | 513.00 m SEK | -5.01 bn SEK |
| Diluted EPS – continuing operations | 3.78 SEK | -37.02 SEK |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Vitrolife AB
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.
More stocks
- A.F.P. Provida (PROVIDA.SN)
- Tamburi Investment Partners SpA (TIP.MI)
- J&J SNACK FOODS CORP (JJSF)
- Neinor Homes SA (HOME.MC)
- STEPAN CO (SCL)
- PHIBRO ANIMAL HEALTH CORP (PAHC)
- Greatech Technology Bhd (0208.KL)
- Central Puerto S.A. (CEPU)
- Taiwan Secom Co Ltd (9917.TW)
- Dom Development SA (DOM.WA)
- Chemometec A/S (CHEMM.CO)
- Shenzhen Colibri Technologies Co Ltd (002957.SZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.